Clinicopathological analysis showed that the ZKSCAN3 expression level was significantly and positively correlated with aggressive pathological features of prostate cancer (e.g., perineural invasion) and the risk of postoperative recurrence, suggesting that it could be used as an independent prognostic marker [78]. This evidence concerns the gene ZKSCAN3 and prostate cancer.